Search research articles
Contact Us
Filters
Showing results (151-160 of 615) with videos related to
Page
of 62
Sort By:
Journal of Bacteriology
|
March 21, 2006
The response regulator CroR modulates expression of the secreted stress-induced SalB protein in Enterococcus faecalis
Cécile Muller, Yoann Le Breton, Thierry Morin, et al.
Revue De Pneumologie Clinique
|
January 1, 1995
[Interstitial pneumonia and mitomycin C. Apropos of a case with analysis of the bronchoalveolar lavage]
D Coëtmeur, E Briens, C Le Breton-Belleguic, et al.
Journal of Medicinal Chemistry
|
July 1, 1983
2-(6-carboxyhexyl)cyclopentanone hexylhydrazone. A potent and time-dependent inhibitor of platelet aggregation
N I Ghali, D L Venton, S C Hung, et al.
Prostaglandins
|
April 1, 1984
2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: a potent inhibitor of the blood platelet cyclo-oxygenase
G C Le Breton, S C Hung, N I Ghali, et al.
The Journal of Biological Chemistry
|
September 17, 1999
Cyclic AMP-dependent phosphorylation of thromboxane A(2) receptor-associated Galpha(13)
J M Manganello, Y Djellas, C Borg, et al.
Molecular Microbiology
|
November 19, 2016
A PTS EII mutant library in Group A Streptococcus identifies a promiscuous man-family PTS transporter influencing SLS-mediated hemolysis
Ganesh S Sundar, Emrul Islam, Kanika Gera, et al.
Human Psychopharmacology
|
July 15, 2003
Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg
Hervé Allain, Danièle Bentué-Ferrer, Stéphanie Le Breton, et al.
Prostaglandins
|
August 1, 1982
Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation
S C Hung, N I Ghali, D L Venton, et al.
Biochimica Et Biophysica Acta
|
February 1, 1983
Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes
S C Hung, N I Ghali, D L Venton, et al.
Blood Pressure. Supplement
|
August 19, 2008
Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy
Jaakko Tuomilehto, Andrzej Tykarski, Peter Baumgart, et al.
Page
of 62
Search research articles
Search
Showing results (151-160 of 615) with videos related to
Sort By:
Page
of 62
Journal of Bacteriology
|
March 21, 2006
The response regulator CroR modulates expression of the secreted stress-induced SalB protein in Enterococcus faecalis
Cécile Muller, Yoann Le Breton, Thierry Morin, et al.
Revue De Pneumologie Clinique
|
January 1, 1995
[Interstitial pneumonia and mitomycin C. Apropos of a case with analysis of the bronchoalveolar lavage]
D Coëtmeur, E Briens, C Le Breton-Belleguic, et al.
Journal of Medicinal Chemistry
|
July 1, 1983
2-(6-carboxyhexyl)cyclopentanone hexylhydrazone. A potent and time-dependent inhibitor of platelet aggregation
N I Ghali, D L Venton, S C Hung, et al.
Prostaglandins
|
April 1, 1984
2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: a potent inhibitor of the blood platelet cyclo-oxygenase
G C Le Breton, S C Hung, N I Ghali, et al.
The Journal of Biological Chemistry
|
September 17, 1999
Cyclic AMP-dependent phosphorylation of thromboxane A(2) receptor-associated Galpha(13)
J M Manganello, Y Djellas, C Borg, et al.
Molecular Microbiology
|
November 19, 2016
A PTS EII mutant library in Group A Streptococcus identifies a promiscuous man-family PTS transporter influencing SLS-mediated hemolysis
Ganesh S Sundar, Emrul Islam, Kanika Gera, et al.
Human Psychopharmacology
|
July 15, 2003
Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg
Hervé Allain, Danièle Bentué-Ferrer, Stéphanie Le Breton, et al.
Prostaglandins
|
August 1, 1982
Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation
S C Hung, N I Ghali, D L Venton, et al.
Biochimica Et Biophysica Acta
|
February 1, 1983
Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes
S C Hung, N I Ghali, D L Venton, et al.
Blood Pressure. Supplement
|
August 19, 2008
Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy
Jaakko Tuomilehto, Andrzej Tykarski, Peter Baumgart, et al.
Page
of 62